TY - JOUR AU - Soria, J. C. AU - Massard, C. AU - Le Chevalier, T. PY - 2010 DA - 2010// TI - Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy? JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdq204 DO - 10.1093/annonc/mdq204 ID - Soria2010 ER - TY - STD TI - Oncology Working Party EMA/CHMP/205/95/Rev.4. In Guideline on the evaluation of anticancer medicinal products in man. London, UK: European Medical Agency; 2012. Accessed 28 March 2013 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/12/WC500119966.pdf UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/12/WC500119966.pdf ID - ref2 ER - TY - STD TI - Bundesinstitut für Arzneimittel und Medizinprodukte: German Medicinal Products Act: Non-official translation. Berlin, Germany: Bundesinstitut für Arzneimittel und Medizinprodukte; 2011. Accessed 28 March 2013 http://hh.juris.de/englisch_amg/index.html UR - http://hh.juris.de/englisch_amg/index.html ID - ref3 ER - TY - BOOK AU - Marckmann, G. AU - Meran, J. G. PY - 2007 DA - 2007// TI - Ethical aspects of research in oncology PB - Deutscher Ärzte-Verlag CY - Cologne, Germany ID - Marckmann2007 ER - TY - JOUR AU - Yothers, G. PY - 2007 DA - 2007// TI - Toward progression-free survival as a primary end point in advanced colorectal cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2007.13.6796 DO - 10.1200/JCO.2007.13.6796 ID - Yothers2007 ER - TY - STD TI - NN: Directive 2001/20/EC of the European parliament and of the council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off J Eur Communities L_121/34 2011. Accessed 19 April 2013 http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:121:0034:0044:en:PDF UR - http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:121:0034:0044:en:PDF ID - ref6 ER - TY - JOUR AU - Brück, P. AU - Pierzchlewska, M. AU - Kaluzna-Oleksy, M. AU - Ramos Lopez, M. E. AU - Rummel, M. AU - Hoelzer, D. AU - Böhme, A. PY - 2012 DA - 2012// TI - Dying of hematologic patients–treatment characteristics in a German University Hospital JO - Support Care Cancer VL - 20 UR - https://doi.org/10.1007/s00520-012-1417-8 DO - 10.1007/s00520-012-1417-8 ID - Brück2012 ER - TY - JOUR AU - Ricevuto, E. AU - Bruera, G. AU - Marchetti, P. PY - 2010 DA - 2010// TI - General principles of chemotherapy JO - Eur Rev Med Pharmacol Sci VL - 14 ID - Ricevuto2010 ER - TY - JOUR AU - McKee, A. E. AU - Farrell, A. T. AU - Pazdur, R. AU - Woodcock, J. PY - 2010 DA - 2010// TI - The role of the U.S. food and drug administration review process: clinical trial endpoints in oncology JO - Oncologist VL - 15 UR - https://doi.org/10.1634/theoncologist.2010-S1-13 DO - 10.1634/theoncologist.2010-S1-13 ID - McKee2010 ER - TY - JOUR AU - Di Leo, A. AU - Bleiberg, H. AU - Buyse, M. PY - 2003 DA - 2003// TI - Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.99.089 DO - 10.1200/JCO.2003.99.089 ID - Di Leo2003 ER - TY - JOUR AU - Markman, M. PY - 2007 DA - 2007// TI - Why overall survival should not be the sole valid primary endpoint of phase 3 ovarian cancer chemotherapy trials JO - Gynecol Oncol VL - 106 UR - https://doi.org/10.1016/j.ygyno.2007.06.005 DO - 10.1016/j.ygyno.2007.06.005 ID - Markman2007 ER - TY - JOUR AU - Guilhot, J. AU - Baccarani, M. AU - Clark, R. E. AU - Cervantes, F. AU - Guilhot, F. AU - Hochhaus, A. AU - Kulikov, S. AU - Mayer, J. AU - Petzer, A. L. AU - Rosti, G. AU - Rousselot, P. AU - Saglio, G. AU - Saussele, S. AU - Simonsson, B. AU - Steegmann, J. L. AU - Zaritskey, A. AU - Hehlmann, R. PY - 2012 DA - 2012// TI - Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-10-383711 DO - 10.1182/blood-2011-10-383711 ID - Guilhot2012 ER - TY - JOUR AU - Pagani, O. AU - Senkus, E. AU - Wood, W. AU - Colleoni, M. AU - Cufer, T. AU - Kyriakides, S. AU - Costa, A. AU - Winer, E. P. AU - Cardoso, F. PY - 2010 DA - 2010// TI - International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? JO - J Natl Cancer Inst VL - 102 UR - https://doi.org/10.1093/jnci/djq029 DO - 10.1093/jnci/djq029 ID - Pagani2010 ER - TY - JOUR AU - Goodin, D. S. AU - Reder, A. T. PY - 2012 DA - 2012// TI - Evidence-based medicine: promise and pitfalls JO - Mult Scler VL - 18 UR - https://doi.org/10.1177/1352458512451660 DO - 10.1177/1352458512451660 ID - Goodin2012 ER - TY - JOUR AU - Gronseth, G. S. AU - Ashman, E. PY - 2012 DA - 2012// TI - The AAN response to evidence-based medicine: promise and pitfalls JO - Mult Scler VL - 18 UR - https://doi.org/10.1177/1352458512448449 DO - 10.1177/1352458512448449 ID - Gronseth2012 ER - TY - JOUR AU - Broglio, K. R. AU - Berry, D. A. PY - 2009 DA - 2009// TI - Detecting an overall survival benefit that is derived from progression-free survival JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp369 DO - 10.1093/jnci/djp369 ID - Broglio2009 ER - TY - JOUR AU - Burzykowski, T. AU - Buyse, M. AU - Piccart-Gebhart, M. J. AU - Sledge, G. AU - Carmichael, J. AU - Lück, H. J. AU - Mackey, J. R. AU - Nabholtz, J. M. AU - Paridaens, R. AU - Biganzoli, L. AU - Jassem, J. AU - Bontenbal, M. AU - Bonneterre, J. AU - Chan, S. AU - Basaran, G. A. AU - Therasse, P. PY - 2008 DA - 2008// TI - Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.10.8407 DO - 10.1200/JCO.2007.10.8407 ID - Burzykowski2008 ER - TY - STD TI - NN: German social code, section 27 paragraph 1. [in German] Accessed 19 April 2013 http://www.sozialgesetzbuch-sgb.de/sgbv/27.html UR - http://www.sozialgesetzbuch-sgb.de/sgbv/27.html ID - ref18 ER - TY - JOUR AU - Sountoulides, P. AU - Metaxa, L. AU - Cindolo, L. PY - 2011 DA - 2011// TI - Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports JO - J Med Case Rep VL - 5 UR - https://doi.org/10.1186/1752-1947-5-429 DO - 10.1186/1752-1947-5-429 ID - Sountoulides2011 ER - TY - JOUR AU - Bianchi, M. AU - Sun, M. AU - Jeldres, C. AU - Shariat, S. F. AU - Trinh, Q. D. AU - Briganti, A. PY - 2012 DA - 2012// TI - Distribution of metastatic sites in renal cell carcinoma: a population-based analysis JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mdr362 DO - 10.1093/annonc/mdr362 ID - Bianchi2012 ER - TY - JOUR AU - Kramer, M. W. M. A. AU - Peters, I. AU - Waalkes, S. AU - Kuczyk, M. A. PY - 2012 DA - 2012// TI - Systemic and surgical management of metastatic renal cell carcinoma: article in German JO - Urologe A VL - 51 UR - https://doi.org/10.1007/s00120-011-2713-5 DO - 10.1007/s00120-011-2713-5 ID - Kramer2012 ER - TY - JOUR AU - Ljungberg, B. AU - Alamdari, F. I. AU - Rasmuson, T. AU - Roos, G. PY - 1999 DA - 1999// TI - Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy JO - BJU Int VL - 84 UR - https://doi.org/10.1046/j.1464-410x.1999.00202.x DO - 10.1046/j.1464-410x.1999.00202.x ID - Ljungberg1999 ER - TY - JOUR AU - Hotte, S. J. AU - Bjarnason, G. A. AU - Heng, D. Y. AU - Jewett, M. A. AU - Kapoor, A. AU - Kollmannsberger, C. PY - 2011 DA - 2011// TI - Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma JO - Curr Oncol VL - 18 ID - Hotte2011 ER - TY - JOUR AU - Herschbach, P. AU - Keller, M. AU - Knight, L. AU - Brandl, T. AU - Huber, B. AU - Henrich, G. PY - 2004 DA - 2004// TI - Psychological problems of cancer patients: a cancer distress screening with a cancer-specific questionnaire JO - Br J Cancer VL - 9 UR - https://doi.org/10.1038/sj.bjc.6601986 DO - 10.1038/sj.bjc.6601986 ID - Herschbach2004 ER - TY - JOUR AU - Cella, D. AU - Escudier, B. AU - Rini, B. AU - Chen, C. AU - Bhattacharyya, H. AU - Tarazi, J. AU - Rosbrook, B. AU - Kim, S. AU - Motzer, R. PY - 2013 DA - 2013// TI - Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial. JO - Br J Cancer VL - 108 UR - https://doi.org/10.1038/bjc.2013.145 DO - 10.1038/bjc.2013.145 ID - Cella2013 ER - TY - JOUR AU - O’Brien, S. G. AU - Guilhot, F. AU - Larson, R. A. AU - Gathmann, I. AU - Baccarani, M. AU - Cervantes, F. AU - Cornelissen, J. J. AU - Fischer, T. AU - Hochhaus, A. AU - Hughes, T. AU - Lechner, K. AU - Nielsen, J. L. AU - Rousselot, P. AU - Reiffers, J. AU - Saglio, G. AU - Shepherd, J. AU - Simonsson, B. AU - Gratwohl, A. AU - Goldman, J. M. AU - Kantarjian, H. AU - Taylor, K. AU - Verhoef, G. AU - Bolton, A. E. AU - Capdeville, R. AU - Druker, B. J. PY - 2003 DA - 2003// TI - Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa022457 DO - 10.1056/NEJMoa022457 ID - O’Brien2003 ER - TY - JOUR AU - Hochhaus, A. AU - O’Brien, S. G. AU - Guilhot, F. AU - Druker, B. J. AU - Branford, S. AU - Foroni, L. AU - Goldman, J. M. AU - Müller, M. C. AU - Radich, J. P. AU - Rudoltz, M. AU - Mone, M. AU - Gathmann, I. AU - Hughes, T. P. AU - Larson, R. A. PY - 2009 DA - 2009// TI - Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia JO - Leukemia VL - 23 UR - https://doi.org/10.1038/leu.2009.38 DO - 10.1038/leu.2009.38 ID - Hochhaus2009 ER - TY - STD TI - Ehninger G, Wörmann B: Benefit assessment from a German medical society’s point of view [in German]. Berlin: German Society for Hematology and Oncology; (2012) Accessed 02 August 2012 http://www.dgho.de/informationen/nachrichten/Vortrag%20Berlin%20GE%202012%20gekuerzt.pdf UR - http://www.dgho.de/informationen/nachrichten/Vortrag%20Berlin%20GE%202012%20gekuerzt.pdf ID - ref28 ER - TY - CHAP AU - Buettner, R. AU - Wolf, J. AU - Thomas, R. K. PY - 2013 DA - 2013// TI - Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment BT - J Clin Oncol ID - Buettner2013 ER - TY - JOUR AU - Rini, B. I. AU - Escudier, B. AU - Tomczak, P. AU - Kaprin, A. AU - Szczylik, C. AU - Hutson, T. E. AU - Michaelson, M. D. AU - Gorbunova, V. A. AU - Gore, M. E. AU - Rusakov, I. G. AU - Negrier, S. AU - Ou, Y. C. AU - Castellano, D. AU - Lim, H. Y. AU - Uemura, H. AU - Tarazi, J. AU - Cella, D. AU - Chen, C. AU - Rosbrook, B. AU - Kim, S. AU - Motzer, R. J. PY - 2011 DA - 2011// TI - Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial JO - Lancet VL - 378 UR - https://doi.org/10.1016/S0140-6736(11)61613-9 DO - 10.1016/S0140-6736(11)61613-9 ID - Rini2011 ER - TY - JOUR AU - Heiss, M. M. AU - Murawa, P. AU - Koralewski, P. AU - Kutarska, E. AU - Kolesnik, O. O. AU - Ivanchenko, V. V. AU - Dudnichenko, A. S. AU - Aleknaviciene, B. AU - Razbadauskas, A. AU - Gore, M. AU - Ganea-Motan, E. AU - Ciuleanu, T. AU - Wimberger, P. AU - Schmittel, A. AU - Schmalfeldt, B. AU - Burges, A. AU - Bokemeyer, C. AU - Lindhofer, H. AU - Lahr, A. AU - Parsons, S. L. PY - 2010 DA - 2010// TI - The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial JO - Int J Cancer VL - 127 UR - https://doi.org/10.1002/ijc.25423 DO - 10.1002/ijc.25423 ID - Heiss2010 ER - TY - JOUR AU - Mathews, H. F. AU - Lannin, D. R. AU - Mitchell, J. P. PY - 1994 DA - 1994// TI - Coming to terms with advanced breast cancer: black women’s narratives from eastern North Carolina JO - Soc Sci Med VL - 38 UR - https://doi.org/10.1016/0277-9536(94)90151-1 DO - 10.1016/0277-9536(94)90151-1 ID - Mathews1994 ER - TY - JOUR AU - Gralow, J. R. AU - Burstein, H. J. AU - Wood, W. AU - Hortobagyi, G. N. AU - Gianni, L. AU - Von Minckwitz, G. AU - Buzdar, A. U. AU - Smith, I. E. AU - Symmans, W. F. AU - Singh, B. AU - Winer, E. P. PY - 2008 DA - 2008// TI - Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.3510 DO - 10.1200/JCO.2007.15.3510 ID - Gralow2008 ER - TY - JOUR AU - Silvestri, G. AU - Pritchard, R. AU - Welch, H. G. PY - 1998 DA - 1998// TI - Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews JO - Brit Med J VL - 317 UR - https://doi.org/10.1136/bmj.317.7161.771 DO - 10.1136/bmj.317.7161.771 ID - Silvestri1998 ER - TY - JOUR AU - Borner, M. M. AU - Schoffski, P. AU - De Wit, R. AU - Caponigro, F. AU - Comella, G. AU - Sulkes, A. AU - Greim, G. AU - Peters, G. J. AU - van der Born, K. AU - Wanders, J. AU - De Boer, R. F. AU - Martin, C. AU - Fumoleau, P. PY - 2002 DA - 2002// TI - Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer JO - Eur J Cancer VL - 38 UR - https://doi.org/10.1016/S0959-8049(01)00371-9 DO - 10.1016/S0959-8049(01)00371-9 ID - Borner2002 ER - TY - JOUR AU - Thomas, R. AU - Godward, S. AU - Makris, A. AU - Bloomfield, D. AU - Moody, A. M. AU - Williams, M. PY - 2004 DA - 2004// TI - Giving patients a choice improves quality of life: a multi-centre, investigator-blind, randomised, crossover study comparing letrozole with anastrozole JO - Clin Oncol (R Coll Radiol) VL - 16 UR - https://doi.org/10.1016/j.clon.2004.06.023 DO - 10.1016/j.clon.2004.06.023 ID - Thomas2004 ER - TY - JOUR AU - Emkey, R. AU - Koltun, W. AU - Beusterien, K. AU - Seidman, L. AU - Kivitz, A. AU - Devas, V. AU - Masanauskaite, D. PY - 2005 DA - 2005// TI - Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the boniva alendronate trial in osteoporosis (BALTO) JO - Curr Med Res Opin VL - 2 UR - https://doi.org/10.1185/030079905X74862 DO - 10.1185/030079905X74862 ID - Emkey2005 ER - TY - JOUR AU - Twelves, C. AU - Gollins, S. AU - Grieve, R. AU - Samuel, L. PY - 2006 DA - 2006// TI - A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer JO - Ann Oncol VL - 17 UR - https://doi.org/10.1093/annonc/mdj023 DO - 10.1093/annonc/mdj023 ID - Twelves2006 ER - TY - JOUR AU - Albany, C. AU - Brames, M. J. AU - Fausel, C. AU - Johnson, C. S. AU - Picus, J. AU - Einhorn, L. H. PY - 2012 DA - 2012// TI - Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.39.5558 DO - 10.1200/JCO.2011.39.5558 ID - Albany2012 ER - TY - JOUR AU - Escudier, B. J. AU - Porta, C. AU - Bono, B. AU - De, G. U. AU - Parikh, O. AU - Hawkins, R. E. AU - Sevin, E. AU - Negrier, S. AU - Khan, S. AU - McCann, L. AU - Mehmud, F. AU - Cella, D. PY - 2012 DA - 2012// TI - Patient preference between pazopanib and sunitinib: results of a randomized double-blind, placebo-controlled, cross-over study in patients with metastatic renal cell carcinoma (mRCC)—PISCES study, NCT 01064310 JO - J Clin Oncol VL - 30 ID - Escudier2012 ER - TY - STD TI - Großelfinger R, Herrmann-Frank A, Bender R, Kiefer C, Kromp M, Lange S: Stem cell transplantation in multiple myeloma: IQWiG Report N05–03C [in German]. : IQWiG Reports 85; 1–195. 2011. Accessed 22 April 2013 https://www.iqwig.de/download/N05-03C_Abschlussbericht_Stammzelltransplantation_bei_Multiplem_Myelom.pdf UR - https://www.iqwig.de/download/N05-03C_Abschlussbericht_Stammzelltransplantation_bei_Multiplem_Myelom.pdf ID - ref41 ER - TY - JOUR AU - Mühlbacher, A. C. AU - Nübling, M. PY - 2011 DA - 2011// TI - Analysis of physicians’ perspectives versus patients’ preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma JO - Eur J Health Econ VL - 12 UR - https://doi.org/10.1007/s10198-010-0218-6 DO - 10.1007/s10198-010-0218-6 ID - Mühlbacher2011 ER -